[PHARMA] QoQ Annualized Quarter Result on 31-Dec-2010 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
25-Feb-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
31-Dec-2010 [#4]
Profit Trend
QoQ- -30.18%
YoY- -49.52%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Revenue 1,537,593 1,563,526 1,541,312 1,378,348 1,336,309 1,335,790 1,270,240 13.56%
PBT 75,757 82,344 87,168 45,462 64,217 65,516 49,724 32.37%
Tax -21,620 -23,056 -24,772 -15,152 -21,201 -17,862 -12,488 44.13%
NP 54,137 59,288 62,396 30,310 43,016 47,654 37,236 28.30%
-
NP to SH 53,620 58,808 61,936 30,384 43,520 48,108 37,228 27.50%
-
Tax Rate 28.54% 28.00% 28.42% 33.33% 33.01% 27.26% 25.11% -
Total Cost 1,483,456 1,504,238 1,478,916 1,348,038 1,293,293 1,288,136 1,233,004 13.10%
-
Net Worth 464,307 451,381 437,661 421,524 424,715 417,306 439,675 3.69%
Dividend
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Div - - - 10,698 67,041 100,581 - -
Div Payout % - - - 35.21% 154.05% 209.07% - -
Equity
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Net Worth 464,307 451,381 437,661 421,524 424,715 417,306 439,675 3.69%
NOSH 106,983 106,962 107,007 106,985 106,981 107,001 106,977 0.00%
Ratio Analysis
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
NP Margin 3.52% 3.79% 4.05% 2.20% 3.22% 3.57% 2.93% -
ROE 11.55% 13.03% 14.15% 7.21% 10.25% 11.53% 8.47% -
Per Share
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
RPS 1,437.23 1,461.75 1,440.38 1,288.35 1,249.11 1,248.38 1,187.40 13.56%
EPS 50.12 54.98 57.88 28.40 40.68 44.96 34.80 27.50%
DPS 0.00 0.00 0.00 10.00 62.67 94.00 0.00 -
NAPS 4.34 4.22 4.09 3.94 3.97 3.90 4.11 3.69%
Adjusted Per Share Value based on latest NOSH - 106,919
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
RPS 106.68 108.48 106.94 95.64 92.72 92.68 88.13 13.56%
EPS 3.72 4.08 4.30 2.11 3.02 3.34 2.58 27.60%
DPS 0.00 0.00 0.00 0.74 4.65 6.98 0.00 -
NAPS 0.3222 0.3132 0.3037 0.2925 0.2947 0.2895 0.3051 3.69%
Price Multiplier on Financial Quarter End Date
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Date 30/09/11 30/06/11 31/03/11 30/12/10 30/09/10 30/06/10 31/03/10 -
Price 5.90 5.90 5.73 5.31 4.98 4.98 4.27 -
P/RPS 0.41 0.40 0.40 0.41 0.40 0.40 0.36 9.04%
P/EPS 11.77 10.73 9.90 18.70 12.24 11.08 12.27 -2.73%
EY 8.49 9.32 10.10 5.35 8.17 9.03 8.15 2.75%
DY 0.00 0.00 0.00 1.88 12.58 18.88 0.00 -
P/NAPS 1.36 1.40 1.40 1.35 1.25 1.28 1.04 19.56%
Price Multiplier on Announcement Date
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Date 01/11/11 10/08/11 13/05/11 25/02/11 04/11/10 11/08/10 26/05/10 -
Price 5.90 5.90 5.05 5.35 4.92 4.95 4.71 -
P/RPS 0.41 0.40 0.35 0.42 0.39 0.40 0.40 1.65%
P/EPS 11.77 10.73 8.72 18.84 12.09 11.01 13.53 -8.86%
EY 8.49 9.32 11.46 5.31 8.27 9.08 7.39 9.68%
DY 0.00 0.00 0.00 1.87 12.74 18.99 0.00 -
P/NAPS 1.36 1.40 1.23 1.36 1.24 1.27 1.15 11.81%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment